News
-
Christmas arrangements
The NCPE will not be processing RR/HTA submissions between December 20th 2024 and 3rd January 2025 (incl). Final date for receipt of submissions will be Thursday 19th December 2024. We will re-open for receiving submissions on Monday 6th January 2025. We would like to wish all a Happy Christmas and […]
-
Update to the Budget Impact Model Template
Version 2.0 of the Budget Impact Model was published on 29th of October 2024 and replaces version 1.8. The new version is available here For those companies who have already started to prepare a Budget Impact Model, the previous version of the template (Version 1.8) will be acceptable until the […]
-
Update to Full Submission Template
Version 3.0 of the Full HTA Submission Template is available here. This template, to be completed by Applicants, outlines the content and format of the written submission to the NCPE as part of a full HTA. For those companies who have already started to prepare a full HTA submission, the […]
-
NCPE Head of Strategy appointed as European HTA Coordination group Chair
Dr. Roisin Adams, NCPE elected as Chair of the Health Technology Assessment Coordination Group. On 28 November 2022, the HTA Coordination Group (HTACG) elected its Chair, Dr. Roisin Adams, National Centre for Pharmacoeconomics, Ireland and co-chairs, Niklas Hedberg Dental and Pharmaceuticals Benefits Agency, Sweden and Marco Marchetti, National Agency for […]
-
Update to Submission Templates
Notice to Applicants: Please refer to updated versions of the RR Submission Template v2.2, Applicant Template v2.1, and the Submission Checklist v1.4 when making submissions. These are available from the Submission Templates section of the website.
-
Updated NCPE Rapid Review Applicant Submission Template
Version 2.1 of the Rapid Review Submission templates includes a requirement to submit the NCPE Budget Impact Model Template for all Rapid Review submissions. Version 2.1 of this template was published on 07 April 2022 and replaces version 2.0. Submissions using the old template (version 2.0) will be accepted until 12 May 2022.
-
Notice for Applicants:
Notice for Applicants: Please refer to updated versions of the Guidelines for Inclusion of Drug Costs v3.1, Applicant submission template v2. and the Budget Impact Model Template v1.5 when making submissions.
-
COVID-19 Evidence Review Group
Latest Updates…
-
Press Release HAG EUNETHTA21
Press Release HAG EUNETHTA21 – Professor Michael Barry, Director of the National Centre for Pharmacoeconomics joins the inaugural Heads of Agency Group.
-
Covid updates
http://www.ncpe.ie/research/covid-19/
